Parents Scrambling After Asthma Inhaler Flovent Removed From Market
WEDNESDAY, Feb. 21, 2024 -- A popular asthma inhaler was discontinued on Jan. 1, and the business move has left families scrambling to find a replacement for their kids.Flovent was one of the most commonly prescribed drugs for childhood asthma, but... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 21, 2024 Category: General Medicine Source Type: news

Electric cars could boost kids' health, study finds
Millions of childhood asthma attacks would be avoided and hundreds of infant lives saved by 2050 if the U.S. transitioned entirely to electric vehicles (EVs) powered by renewable energy, according to new research from the American Lung Association (ALA). Why it matters: Children are especially…#ala #epa #departmentofenergy #willbarrett #haroldwimmer #reality (Source: Reuters: Health)
Source: Reuters: Health - February 21, 2024 Category: Consumer Health News Source Type: news

Peninsula biotech halts 2 clinical trials, stock loses 70% of value
The company, focused on inflammatory diseases such as asthma and eczema, has lost close to a half-billion dollars since it started in 2015. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 20, 2024 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Groundbreaking Food Allergy Treatment Research to Be Unveiled at 2024 American Academy of Allergy, Asthma & amp; Immunology Annual Meeting
Media Advisory for Late Breaking Symposium at the 2024 AAAAI Annual Meeting MILWAUKEE, Feb. 19, 2024 /PRNewswire-PRWeb/ -- Renowned allergist Dr. Robert A. Wood, MD FAAAAI, will present detailed findings from a Phase 3 clinical trial that will have significant impact in the world of food... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 19, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news

Drying your laundry inside could pose a serious risk to your health, expert warns
The common practice could increase your risk of allergic reactions, asthma attacks, weight loss and even lead to hospitalisation in severe cases, according to an expert. (Source: Daily Express - Health)
Source: Daily Express - Health - February 18, 2024 Category: Consumer Health News Source Type: news

Expanded Use of Xolair to Treat Food Allergies Approved by the FDA
FRIDAY, Feb. 16, 2024 -- The U.S. Food and Drug Administration has expanded the use of the asthma drug Xolair (omalizumab) to help prevent anaphylactic reactions.Xolair is an injected drug and is not meant as a substitute for EpiPens or other... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 17, 2024 Category: Pharmaceuticals Source Type: news

FDA Expands Use of Asthma Med Xolair to Treat Food Allergies
FRIDAY, Feb. 16, 2024 -- People threatened by accidental exposure to foods they ' re allergic to may have a new weapon of defense: On Friday, the U.S. Food and Drug Administration expanded the use of the asthma drug Xolair to help prevent... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 16, 2024 Category: General Medicine Source Type: news

FDA expands use of asthma drug Xolair to treat severe food allergies
A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions (Source: ABC News: Health)
Source: ABC News: Health - February 16, 2024 Category: Consumer Health News Tags: Health Source Type: news

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2   Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16  February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food ...
Source: Roche Investor Update - February 16, 2024 Category: Pharmaceuticals Source Type: news

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2   Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16  February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food ...
Source: Roche Media News - February 16, 2024 Category: Pharmaceuticals Source Type: news

North Carolina biotech tops $400M in funding for asthma treatment
A Chapel Hill company thinks its drug has the potential to be the first oral therapy to treat patients with severe, uncontrolled asthma. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 15, 2024 Category: Pharmaceuticals Authors: Zac Ezzone Source Type: news

Ozone and PM2.5 Exposure is Associated with Nasal Key Driver Gene Expression in People with Asthma
Six key driver genes were identified for ozone and three key drivers for PM2.5 exposure. MILWAUKEE, Feb. 15, 2024 /PRNewswire-PRWeb/ -- Nasal key driver gene expression representing T-cell mediated immune processes is associated with ozone and fine particulate matter (PM2.5) exposure in... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 15, 2024 Category: Pharmaceuticals Tags: SVY Source Type: news

Non-Lesional Filaggrin Expression is Predictive of Asthma Development in Children with Atopic Dermatitis
Low Filaggrin expression in children aged 2 to 3 years old is a significant predictor of school-age asthma. MILWAUKEE, Feb. 14, 2024 /PRNewswire-PRWeb/ -- Filaggrin (FLG) expression in non-lesional skin and observations of the skin barrier can lead to early diagnosis for children with... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 14, 2024 Category: Pharmaceuticals Tags: SVY Source Type: news

North Carolina biotech tops $400M in funding for asthma treatment
A Chapel Hill company thinks its drug has the potential to be the first oral therapy to treat patients with severe, uncontrolled asthma. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 14, 2024 Category: Biotechnology Authors: Zac Ezzone Source Type: news

My son died from an asthma attack and now I'm campaigning to make inhalers free in England - people shouldn't have to 'pay to breathe'
Donna Smitheman, 44, from Chesterfield, Derbyshire, lost her son, Jordan Ashley Smitheman, 25, in 2023 following an asthma attack. She is now campaigning to make inhalers free (Source: the Mail online | Health)
Source: the Mail online | Health - February 13, 2024 Category: Consumer Health News Source Type: news